EU Prioritizing Pfizer-BioNTech COVID-19 Vaccine


More than 3000 people per day in India have died of COVID-19 since April 28.

This article was originally published in ContagionLive.

The European Union (EU) is prioritizing other COVID-19 vaccine opportunities instead of AstraZeneca after the company failed to meet delivery targets because of concerns over the vaccine efficacy against COVID-19 variants in circulation.

The EU did not renew their order for the vaccine after June and recently concluded a deal with Pfizer for up to 1.8 billion doses of their vaccine to be delivered through 2023.

However, the EU has said that it has not completely ruled out renewing the contract with AstraZeneca at some point in the future.

In Germany, the government is set to make the Johnson & Johnson vaccine available to all adults under the age of 60.

The country will be receiving another delivery of the vaccine by July, containing around 10 million doses. Around 32.3% of the country’s population has received at least 1 dose of a vaccine and 9.1% are now fully vaccinated.

In India, COVID-19 is still wreaking havoc on an under-vaccinated population.

Only 2.75% of the country’s 1.3 billion people have been fully vaccinated. Since April 28, over 3000 people have died due to COVID-19 every day.


324.31 million

22.53 per 100

United States

259.72 million

77.66 per 100


168.3 million

12.2 per 100

United Kingdom

53.04 million

78.13 per 100


46.88 million

22.05 per 100


34.41 million

41.07 per 100


25.41 million

37.29 per 100


24.92 million

29.55 per 100


21.99 million

8.04 per 100


21.75 million

14.91 per 100

Data Table per Our World in Data (May 9, 2021, 12 AM EST)

In the US, vaccinations across the country continue to slow down from the one time high in April. Despite this, cases of COVID-19 also continue to fall, with the country recording 21,392 new cases on Sunday, down from the same time last week. The percentage of fully vaccinated Americans now stands at 34.4%.



83.79 per 100



69.71 per 100

New York


87.56 per 100



76.50 per 100



85.55 per 100



80.07 per 100



76.39 per 100

New Jersey


89.32 per 100



76.98 per 100

North Carolina


84.74 per 100

Data Table per CDC COVID-19 Tracker (May 9, 2021, 6 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

Novavax Combination Vaccine Shows Positive Preclinical Results

Inovio Announces Results from its Phase 2 COVID-19 Vaccine Trial

China’s Sinopharm COVID-19 Vaccine Approved by WHO

Related Videos
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Mikkael Sekeres, MD:
Julia Moore Vogel, PhD, MBA: How Do We Define Long Covid Patients?
Julia Moore Vogel, PhD, MBA: Long Covid Care Lacks Urgency
Balancing COVID-19 Risk and Wellness in Patients with Rheumatic Diseases
Exploring Patient Experiences, Challenges of Rheumatic Disease Management During the Pandemic
© 2024 MJH Life Sciences

All rights reserved.